Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Betamethasone 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
2 Betamethasone acetate 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
3 Betamethasone benzoate 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
4 Betamethasone dipropionate 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
5 Betamethasone sodium phosphate 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
6 Betamethasone valerate 💬[1] Betamethasone[1] Betamethasone[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 28, 83, 90, 96, 235 💬
7 Cosyntropin 💬[1] Tetracosactide[3] Cosyntropin; Tetracosactide acetate; Tetracosactrin[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 78, 83, 113, 145 💬
8 Glycyrrhiza 💬[1] Licorice[2] Licorice; Liquorice--[4] 46, 53, 83, 224 💬
9 Hydrocortisone 💬[1] Hydrocortisone[3] Cortisol; Hydrocortisone; Hydrocortisonum[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[8] 41, 53, 75, 78, 81, 83, 97, 299 💬
10 Hydrocortisone sodium succinate 💬[1] Hydrocortisone succinate[2] Hydrocortisone hydrogen succinate; Hydrocortisone sodium succinate[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
11 Hydrocortisone succinate 💬[1] Hydrocortisone succinate[2] Hydrocortisone hydrogen succinate; Hydrocortisone sodium succinate[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
12 Methylprednisolone 💬[1] Methylprednisolone[3] Methylprednisolon; Methylprednisolone; Methylprednisolone acetate[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[45] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
13 Methylprednisolone acetate 💬[1] Methylprednisolone[3] Methylprednisolon; Methylprednisolone; Methylprednisolone acetate[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[45] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
14 Prasterone 💬[1] Prasterone[3] Dehydroepiandrosterone; Dhea; Prasterone[3] AR,
ESR1,
ESR2 💬 		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[4] 49, 53, 83, 96 💬
15 Rituximab 💬[1] Rituximab[1] Rituximab[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[52] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
16 Tetracosactide acetate 💬[1] Tetracosactide[3] Cosyntropin; Tetracosactide acetate; Tetracosactrin[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 78, 83, 113, 145 💬